Pristiq (desvenlafaxine) is an antidepressant FDA-approved to treat major depressive disorder (MDD) in adults. It belongs to a class of medications called SNRIs, which work by increasing the activity of two brain chemicals involved in mood regulation: serotonin and norepinephrine. The recommended dose is 50 mg taken once daily, with or without food.
How Pristiq Works in the Brain
Depression is closely linked to low levels of certain chemical messengers in the brain. Pristiq blocks the reabsorption of serotonin and norepinephrine after they’ve been released, keeping more of these chemicals available in the spaces between nerve cells. This increased availability helps restore normal signaling in mood-regulating circuits.
Pristiq is actually the active breakdown product of an older antidepressant, venlafaxine (Effexor). One practical advantage: unlike venlafaxine, Pristiq doesn’t rely on a liver enzyme called CYP2D6 to become active. About 5 to 10 percent of people process drugs through that enzyme very slowly or very quickly, which can make venlafaxine’s effects unpredictable. With Pristiq, your genetic makeup has little impact on how the drug behaves in your body. It’s mostly eliminated unchanged through the kidneys, making its effects more consistent from person to person and reducing the chance of interactions with other medications.
Off-Label Uses
Although MDD is the only FDA-approved indication, doctors sometimes prescribe Pristiq off-label for anxiety disorders, panic disorder, and social anxiety disorder. Small clinical trials have explored its use for generalized social anxiety, with some positive results. SNRIs as a class have also shown benefit for hot flashes during menopause, chronic pain conditions, and diabetic nerve pain, though Pristiq itself doesn’t carry formal approval for any of these.
How Long It Takes to Work
Pristiq doesn’t produce overnight results. You or your family may notice early changes in sleep, appetite, and energy within the first one to two weeks. Meaningful improvement in mood typically takes three to six weeks, and the full benefit may not be apparent for four to eight weeks or longer. This lag is common across antidepressants and doesn’t mean the medication isn’t working.
Common Side Effects
In clinical trials at the standard 50 mg dose, the most frequently reported side effects were nausea (22% vs. 10% on placebo), excessive sweating (10% vs. 4% on placebo), dizziness, insomnia, constipation, drowsiness, and decreased appetite. These effects were dose-dependent: higher doses produced more side effects without adding meaningful antidepressant benefit, which is why 50 mg remains the recommended dose.
Nausea is the side effect most likely to cause someone to stop taking Pristiq early. It tends to be worst during the first week or two and often fades as the body adjusts.
Weight Changes
At the 50 mg dose, patients in clinical trials lost an average of 0.4 kg (just under a pound) over eight weeks, compared to no change on placebo. Decreased appetite affected about 5% of people at this dose. Meaningful weight gain was uncommon, reported in fewer than 2% of participants. In younger patients, weight loss was more pronounced, with about 22% of those on the lower dose losing 3.5% or more of their body weight.
Sexual Side Effects
Like other SNRIs, Pristiq can affect sexual function. At the 50 mg dose, about 4% of men reported decreased sex drive, 3% experienced erectile difficulty, and 1% noticed delayed ejaculation. Rates in women were lower in trials but may be underreported. These effects became more common at higher doses. If sexual side effects are persistent and bothersome, a dose adjustment or medication switch is worth discussing.
Blood Pressure and Monitoring
SNRIs can raise blood pressure, and Pristiq is no exception. The FDA label recommends regular blood pressure checks while taking this medication. If you have pre-existing high blood pressure, it should be well controlled before starting Pristiq. A sustained increase while on the medication may call for a dose reduction or a switch to a different antidepressant.
Why You Shouldn’t Stop Abruptly
Pristiq carries a high risk of discontinuation syndrome, meaning stopping suddenly can trigger a cluster of uncomfortable symptoms within two to four days. These include flu-like feelings (fatigue, headache, body aches, sweating), nausea, dizziness, burning or electric shock sensations, vivid dreams, and mood changes like irritability or anxiety.
The fix is straightforward: gradually tapering the dose under a provider’s guidance rather than stopping cold turkey. If discontinuation symptoms do appear, restarting the medication at the previous dose typically resolves them within 24 hours, after which a slower taper can begin. The tapering timeline varies from person to person, so there’s no single schedule that works for everyone.
Dosing at a Glance
The standard and recommended dose is 50 mg once daily. Clinical trials tested doses up to 400 mg per day, but none outperformed 50 mg for depression relief. Higher doses only increased side effects and the likelihood of stopping treatment early. Pristiq comes as an extended-release tablet that should be swallowed whole, not split or crushed, since the coating controls how the drug is released over time.